BOSTON / Dec 29, 2025 / Business Wire / Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that following evaluation of interim data from the RAMP 203 clinical trial in...Read more
Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomes Timing of the final analysis is event-driven, and SELLAS will announce the occurrence of the...Read more
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) Both studies achieved secondary endpoint of improvements in bone mineral density with strong statistical significance LONDON,...Read more
Company Preparing to Commence Commercialization Following U.S. FDA 510(k) Clearance SARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today...Read more
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the U.S. Food and Drug...Read more
NEW YORK / Dec 29, 2025 / Business Wire / Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted Motiva® implants for approval...Read more
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including a small-molecule GLP-1 receptor...
CLICK TO LEARN MORE| Company | Change | Last Trade |
|---|---|---|
| Praxis Precision Medicines | 36.12 13.43 | $305.07 |
| Belite Bio | 10.24 6.61 | $165.17 |
| Nutex Health | 9.52 5.39 | $186.20 |
| Movano Health | 4.82 154.98 | $7.93 |
| Bolt Biotherapeutics | 4.80 857.14 | $5.36 |
| Regencell Bioscience | 3.72 17.58 | $24.88 |
| Greenwich LifeSciences | 3.61 17.45 | $24.30 |
| Sol-Gel Technologies | 2.69 6.43 | $44.54 |
| Rhythm Pharmaceuticals | 2.43 2.21 | $112.55 |
| Ascendis Pharma | 1.87 0.89 | $210.97 |
| Krystal Biotech | 1.26 0.50 | $253.68 |
| Lipocine | 1.04 19.89 | $6.27 |
| Lyell Immunopharma | 0.98 2.79 | $36.07 |
| Mirum Pharmaceuticals | 0.95 1.20 | $80.21 |
| Omeros | 0.86 5.47 | $16.57 |
| AnaptysBio | 0.84 1.68 | $50.94 |
| BioNTech | 0.74 0.78 | $95.26 |
| Atara Biotherapeutics | 0.70 4.05 | $17.97 |
| Company | Volume | Last Trade |
|---|---|---|
| Mereo BioPharma | 759,192,410 | $0.30 |
| SELLAS Life Sciences | 48,783,261 | $3.37 |
| Reviva Pharmaceuticals | 45,998,520 | $0.29 |
| Incannex Healthcare | 45,827,332 | $0.37 |
| Ultragenyx Pharmaceutical | 39,786,541 | $19.71 |
| Recursion | 39,431,789 | $4.13 |
| Applied Therapeutics | 24,071,306 | $0.11 |
| GT Biopharma | 22,430,522 | $0.92 |
| Palisade Bio | 20,075,445 | $2.48 |
| Vistagen | 19,284,381 | $0.65 |
| Quantum-Si | 16,602,442 | $1.19 |
| ImmunityBio | 15,862,510 | $2.04 |
| Sangamo Therapeutics | 14,656,516 | $0.41 |
| Indaptus Therapeutics | 14,124,721 | $2.73 |
| INOVIO | 13,623,537 | $1.73 |
| Ocugen | 13,404,970 | $1.48 |
| Humacyte | 13,273,170 | $1.02 |
| Rezolute | 12,775,923 | $2.43 |
| Cue Biopharma | 12,005,114 | $0.28 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...
CLICK TO LEARN MORE
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
